UnitedHealthcareMedium ImpactCoverage
Tocilizumab Injection for Intravenous Infusion
Published June 2, 2026Effective July 1, 2026
AI Summary
UnitedHealthcare has revised their Medical Benefit Drug Policy for Tocilizumab injection for intravenous infusion, effective July 1, 2026. This policy update affects coverage and billing requirements for this specialty drug used primarily in rheumatology and oncology practices.
Action Required
By July 1, 2026: Review the updated tocilizumab injection policy bulletin at uhcprovider.com and update billing procedures for intravenous tocilizumab administration. Billing team should verify any changes to prior authorization requirements, coverage criteria, or documentation needs for this specialty drug. Ensure providers are aware of revised policy requirements before treating patients with tocilizumab infusions.
Plan Types
Commercial
Specialties
rheumatology, oncology, gastroenterology